This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Alzheimer’s disease (Early onset)
AD_EO
Alzheimer's disease: A progressive, neurodegenerative disease characterized by loss of function and death of nerve cells in several areas of the brain leading to loss of cognitive function such as memory and language.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
1879 |
4. Check minimum number of eventsNone |
1879 |
5. Include endpointsNone |
1879 |
6. Filter based on genotype QC (FinnGen only) |
1879 |
Control definitions (FinnGen only)
- Control exclude
- G6_ALZHEIMER
Extra metadata
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Alzheimer’s disease (Early onset)
based on the number of shared cases.
Similar with more cases:
- Alzheimer’s disease (Early onset), excluding more controls
- Alzheimer’s disease, wide definition
- Alzheimer’s disease, wide definition, excluding more controls
- Unspecific neurodegenerative disorder
- Any dementia
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1879 | 914 | 965 |
| Unadjusted period prevalence (%) | 0.37 | 0.31 | 0.43 |
| Median age at first event (years) | 76.41 | 74.94 | 77.80 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1642
- Matched controls
- 16418
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
G30.1
ICD-10 Finland
Alzheimer disease with late onset
83.1
323.0
769
172
N06DX01
ATC
memantine; oral
58.5
323.0
923
352
G30.9
ICD-10 Finland
Alzheimer disease, unspecified
384.8
323.0
679
30
F00.00*G30.0
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms
3821.0
323.0
551
*
N06DA02
ATC
donepezil; oral
60.6
323.0
865
296
N06DA03
ATC
rivastigmine; oral, transdermal
39.0
323.0
533
200
F00.10*G30.1
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
77.8
323.0
406
69
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
144.5
323.0
1003
176
G30.0
ICD-10 Finland
Alzheimer disease with early onset
6039.0
323.0
925
*
F0009, G300
ICD-10 Finland
NA
+∞
257.2
240
*
N05AX08
ATC
risperidone; systemic
10.5
239.9
520
696
F00.00
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms
2292.0
200.1
190
*
G30
ICD-10 Finland
Alzheimer disease
101.1
179.8
196
22
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
7.8
176.2
456
773
F0019, G301
ICD-10 Finland
NA
+∞
167.6
158
*
N06DA04
ATC
galantamine; oral
27.5
165.6
231
97
F03
ICD-10 Finland
Unspecified dementia
7.3
147.0
391
672
F00.10
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
36.7
146.1
189
58
G30.8
ICD-10 Finland
Other Alzheimer disease
36.8
133.2
172
52
P20
ICPC
Memory disturbance
4.9
131.4
512
1388
F009, G309
ICD-10 Finland
NA
+∞
128.9
122
*
N05AH04
ATC
quetiapine; oral
5.4
126.8
440
1044
P70
ICPC
Dementia
17.4
120.4
195
126
TAB00
NOMESCO Finland
Lumbar puncture
13.7
108.4
194
159
F00.20*G30.8
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms
21.1
72.8
109
55
F00.9
ICD-10 Finland
Dementia in Alzheimer disease, unspecified
38.0
70.6
90
25
XA800
NOMESCO Finland
Neuropsychological investigation
9.6
64.8
137
154
SPAT1053
SPAT
Memory test
2.8
54.9
426
1820
F06.7
ICD-10 Finland
Mild cognitive disorder
6.8
53.9
142
225
N03AG01
ATC
valproic acid; systemic, rectal
5.3
47.2
153
314
N05BA04
ATC
oxazepam; oral
2.4
45.0
498
2548
SPAT1245
SPAT
Provision of support and information to patient’s family members
3.9
41.5
185
520
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
4.1
40.2
166
435
N06AB10
ATC
escitalopram; oral
2.8
40.1
296
1201
R41.3
ICD-10 Finland
Other amnesia
5.6
37.7
114
215
F00.09
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, presenile onset information on additional symptoms is lacking
+∞
37.6
36
*
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
3.5
35.6
176
538
Z75.5
ICD-10 Finland
Holiday relief care
7.4
35.2
86
122
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.0
34.3
627
3897
R53
ICD-10 Finland
Malaise and fatigue
2.1
32.3
441
2425
N05AD01
ATC
haloperidol; systemic
4.2
31.9
126
316
N06AB04
ATC
citalopram; systemic
2.2
31.7
404
2150
F05.1
ICD-10 Finland
Delirium superimposed on dementia
16.6
31.2
50
31
F00.01
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, presenile onset other additional symptoms, mainly paranoidism
318.6
30.9
31
*
N05BA06
ATC
lorazepam; systemic, sublingual
3.5
30.6
154
476
N06AX11
ATC
mirtazapine; oral
2.0
30.6
511
3037
N05AH03
ATC
olanzapine; systemic
4.9
30.3
103
222
N07AA05
ATC
NA
296.9
28.9
29
*
A28
ICPC
Limited function/disability NOS
2.1
28.6
401
2210
F0029, G308
ICD-10 Finland
NA
+∞
28.2
27
*
F0014, G301
ICD-10 Finland
NA
+∞
27.2
26
*
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
2.6
25.4
208
883
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.8
25.3
606
4030
Z02.4
ICD-10 Finland
Examination for driving licence
0.4
24.5
89
2236
SPAT1234
SPAT
Support of social functional capacity
2.9
24.0
156
575
F00.20
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms
11.3
22.4
42
38
F00
ICD-10 Finland
Dementia in Alzheimer disease
24.3
22.2
31
13
F0004, G300
ICD-10 Finland
NA
+∞
21.9
21
*
Z2445
NOMESCO Finland
Psychologist
5.7
21.7
63
114
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
3.2
21.7
117
381
N05AD03
ATC
melperone; systemic
4.8
21.6
73
157
SPAT1216
SPAT
Assessment of functional ability
2.0
21.3
334
1899
A06AD11
ATC
lactulose; oral
1.8
21.2
410
2507
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.0
21.2
309
1706
F00.1
ICD-10 Finland
Dementia in Alzheimer disease with late onset
60.8
20.9
24
*
WYA20
NOMESCO Finland
Home visit
4.8
20.8
70
150
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
2.2
19.8
215
1047
F00.0
ICD-10 Finland
Dementia in Alzheimer disease with early onset
106.3
19.6
21
*
S18
ICPC
Laceration/cut
0.5
18.9
253
4109
F00.19
ICD-10 Finland
Dementia in Alzheimer's disease with late onset without information about additional symptoms
70.7
18.7
21
*
F001, G301
ICD-10 Finland
NA
44.5
18.3
22
5
R56.8
ICD-10 Finland
Other and unspecified convulsions
3.2
18.1
98
321
SAB01
NOMESCO Finland
Restricted oral and dental health check by dental hygienist or dental assistant
3.0
17.8
107
375
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
5.3
17.8
54
104
F00.14
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms of mixed type
67.3
17.7
20
*
F000, G300
ICD-10 Finland
NA
+∞
17.7
17
*
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.8
17.7
374
2336
G91.2
ICD-10 Finland
Normal-pressure hydrocephalus
4.8
17.2
57
121
N02AJ06
ATC
codeine and paracetamol; systemic
0.5
17.0
156
2836
R41.0
ICD-10 Finland
Disorientation, unspecified
2.9
16.6
101
357
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.8
16.0
310
1875
F00.04
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, presenile onset other additional symptoms of mixed type
+∞
15.6
15
*
SPAT1153
SPAT
Removal of sutures
0.5
15.5
175
3003
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.4
15.4
138
611
SPAT1254
SPAT
Administration of medicine
1.8
15.2
287
1723
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.8
14.7
304
1875
F0001, G300
ICD-10 Finland
NA
+∞
14.6
14
*
F0009, G309
ICD-10 Finland
NA
+∞
14.6
14
*
G31.0
ICD-10 Finland
Circumscribed brain atrophy
10.1
14.5
28
28
SPAT1251
SPAT
Organisation of medication
2.7
14.4
100
385
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
0.5
14.2
112
2147
AA5DR
NOMESCO Finland
Brain metabolism PET with CT
42.9
14.1
17
*
Z13.3
ICD-10 Finland
Special screening examination for mental and behavioural disorders
42.9
14.1
17
*
G40.9
ICD-10 Finland
Epilepsy, unspecified
3.2
14.1
74
238
130
Kela drug reimbursment
Malignant tumour
0.3
13.8
24
855
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
2.6
13.7
103
414
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
2.5
13.4
106
440
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.3
13.3
131
607
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.7
12.9
289
1818
S72.0
ICD-10 Finland
Fracture of neck of femur
2.2
12.2
133
645
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
0.5
12.0
97
1852
L28
ICPC
Limited function/disability (L)
1.6
11.5
308
2036
3310A
ICD-9 Finland
Other cerebral degenerations, Alzheimer's disease
+∞
11.5
11
*
R55
ICD-10 Finland
Syncope and collapse
1.8
11.1
217
1307
LAITO
NOMESCO Finland
NA
21.6
10.7
15
7
F00.02
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, presenile onset other additional symptoms, mainly illusions
+∞
10.4
10
*
N07AA06
ATC
NA
+∞
10.4
10
*
L82
ICD-10 Finland
Seborrhoeic keratosis
0.5
10.4
66
1365
N02AA05
ATC
oxycodone; systemic
1.6
10.3
280
1855
F00.11
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms, mainly paranoidism
40.3
10.0
12
*
AA1AD
NOMESCO Finland
CT of head and brain
1.5
9.6
387
2806
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.7
9.6
205
1268
R23.8
ICD-10 Finland
Other and unspecified skin changes
0.5
9.6
62
1275
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
2.8
9.6
60
219
207
Kela drug reimbursment
Chronic arrhythmias
0.6
9.5
132
2171
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
0.5
9.5
87
1600
-
ICD-10 Finland
NA
3.0
9.4
52
176
L17
ICPC
Foot/toe symptom/complaint
0.6
9.2
134
2177
J01CA08
ATC
pivmecillinam; oral
1.4
9.1
580
4594
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
2.0
9.0
119
627
L57.0
ICD-10 Finland
Actinic keratosis
0.5
9.0
66
1300
NFB20
NOMESCO Finland
Primary partial prosthetic replacement of hip joint using cement, other or unspecified
2.3
8.9
84
383
N02BE01
ATC
paracetamol; systemic, rectal
1.4
8.9
1206
10861
H02AB02
ATC
dexamethasone; systemic
0.4
8.8
29
767
E86
ICD-10 Finland
Volume depletion
2.5
8.8
67
276
H04AA01
ATC
glucagon; nasal, parenteral
4.8
8.6
27
57
F0011, G301
ICD-10 Finland
NA
90.5
8.4
9
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
0.7
8.3
388
4995
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.6
8.2
209
1354
S06.0
ICD-10 Finland
Concussion
1.8
8.2
147
862
K86
ICPC
Hypertension uncomplicated
0.5
8.1
53
1087
L08
ICPC
Shoulder symptom/complaint
0.5
8.1
85
1508
N06AB06
ATC
sertraline; oral
1.9
8.1
112
601
R1250
NOMESCO Finland
Evaluation of functional capability
3.5
8.1
36
105
H81
ICPC
Excessive ear wax
0.6
8.1
108
1792
N05CD07
ATC
temazepam; oral
1.5
8.1
287
2021
WX402
NOMESCO Finland
General anaesthesia
0.4
7.9
40
897
H02AB06
ATC
prednisolone; systemic
0.7
7.9
444
5563
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
3.5
7.9
35
102
A03FA01
ATC
metoclopramide; systemic, rectal
0.6
7.9
133
2088
DFF00
NOMESCO Finland
Pure tone audiometry
0.4
7.8
30
746
B03BA03
ATC
hydroxocobalamin; parenteral
1.8
7.7
133
769
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
0.6
7.7
139
2151
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
3.7
7.7
31
84
R05
ICPC
Cough
0.6
7.6
100
1674
R99
ICD-10 Finland
Other ill-defined and unspecified causes of mortality
2.8
7.6
46
167
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
0.6
7.5
126
1982
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
0.4
7.4
33
772
JN4AD
NOMESCO Finland
Body CT examination
0.3
7.4
20
575
F0002, G300
ICD-10 Finland
NA
+∞
7.3
7
*
F0001, G301
ICD-10 Finland
NA
+∞
7.3
7
*
B01AF02
ATC
apixaban; oral
0.5
7.3
63
1180
C04AE01
ATC
ergoloid mesylates; systemic
3.3
7.3
34
104
WX100
NOMESCO Finland
Conjunctival surface anesthesia
0.5
7.1
72
1288
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
5.3
7.1
20
38
AAA20
NOMESCO Finland
Insertion of intraventricular pressure monitoring device
10.1
7.0
13
13
A98
ICPC
Health maint/preventive medicine
0.8
7.0
915
10252
SPAT1229
SPAT
Assessment of need for aid
1.7
6.9
146
899
G31.8
ICD-10 Finland
Other specified degenerative diseases of nervous system
5.5
6.9
19
35
N06AX26
ATC
vortioxetine; oral
2.5
6.9
50
203
M01AH05
ATC
etoricoxib; oral
0.7
6.9
401
5023
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.5
6.8
226
1564
S72.1
ICD-10 Finland
Pertrochanteric fracture
2.1
6.8
73
357
A69
ICPC
General and Unspecified, Other reason for encounter NEC
2.4
6.8
52
217
H84
ICPC
Presbyacusis
0.3
6.8
11
406
K85
ICPC
Elevated blood pressure
0.6
6.7
87
1456
F009, F03
ICD-10 Finland
NA
22.6
6.7
9
*
G40.2
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
4.9
6.7
20
41
M79.6
ICD-10 Finland
Pain in limb
0.7
6.6
244
3286
F06.9
ICD-10 Finland
Unspecified mental disorder due to brain damage and dysfunction and to physical disease
12.3
6.6
11
9
F05.9
ICD-10 Finland
Delirium, unspecified
2.4
6.4
50
211
G31.1
ICD-10 Finland
Senile degeneration of brain, not elsewhere classified
14.4
6.4
10
7
I48.0
ICD-10 Finland
Paroxysmal atrial fibrillation
0.3
6.4
16
475
L03
ICPC
Low back symptom/complaint
0.6
6.4
122
1864
R41
ICD-10 Finland
Other symptoms and signs involving cognitive functions and awareness
4.9
6.4
19
39
F0009, G301
ICD-10 Finland
NA
+∞
6.3
6
*
F0003, G300
ICD-10 Finland
NA
+∞
6.3
6
*
F00.03
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, presenil onset other additional symptoms, mainly depression
+∞
6.3
6
*
F0023, G308
ICD-10 Finland
NA
+∞
6.3
6
*
SAD01
NOMESCO Finland
Assessment of need for oral health care, standard
1.8
6.2
108
630
R06.0
ICD-10 Finland
Dyspnoea
0.7
6.2
224
3036
E000001
ATC
NA
1.4
6.2
263
1911
2900A
ICD-9 Finland
Senile and presenile organic psychotic conditions, Senile dementia, uncomplicated
6.3
6.2
15
24
K80
ICPC
Cardiac arrhythmia NOS
0.4
6.1
23
576
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
0.6
6.1
87
1422
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
1.5
6.0
178
1198
W19
ICD-10 Finland
Unspecified fall
1.6
6.0
148
951
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
199
42
52.87
307.65
1.0
1.0
ng/l
505.6
726.6
1.69
150
20
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
194
42
51.39
307.65
1.0
1.0
ng/l
417.9
251.1
4.51
150
19
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
199
42
52.87
307.65
1.0
1.0
ng/l
61.0
34.4
4.14
151
18
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
195
188
11.46
179.77
1.1
1.3
mg/l
415.3
590.7
4.33
184
179
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
184
167
12.10
176.53
1.1
1.3
e6/l
2.2
40.7
1.35
146
138
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
184
167
12.10
176.53
1.2
1.3
e6/l
120.7
1178.5
0.82
150
141
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
183
166
12.11
175.62
1.1
1.2
mmol/l
3.7
3.9
0.63
172
154
(3044290) Cell count panel - Cerebral spinal fluid
149
142
11.31
137.90
1.1
1.2
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
87
69
13.17
90.16
1.2
1.2
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
61
67
9.38
50.59
1.1
1.2
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
719
10494
0.49
47.33
3.8
4.5
mmol/l
1.5
1.5
1.16
618
9287
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
772
10994
0.49
47.05
4.1
5.1
mmol/l
2.6
2.6
1.28
662
9760
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
734
10626
0.49
46.95
3.8
4.5
mmol/l
4.5
4.5
1.06
639
9514
(3009466) Valproate [Moles/volume] in Serum or Plasma
80
132
6.29
46.68
3.1
4.4
umol/l
317.0
352.3
1.07
65
111
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
694
10187
0.49
45.55
3.4
4.0
mmol/l
1.2
1.3
1.30
588
8951
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
48
66
7.44
33.14
1.0
1.1
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
837
11015
0.57
31.11
4.1
4.9
mmol/l
6.2
6.1
0.77
704
9655
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
801
10611
0.57
29.79
5.7
6.4
mmol/mol
42.7
41.4
2.08
669
9502
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
805
10521
0.59
26.93
15.6
17.3
ml/min/173m2
72.1
69.3
3.15
592
8743
(40768804) Tissue Pathology biopsy report
247
4510
0.48
25.68
1.9
2.3
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
38
57
6.78
24.26
1.0
1.0
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
352
5571
0.55
22.61
3.7
4.2
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
495
3221
1.73
22.25
1.8
1.8
nmol/l
1215.8
1174.4
0.46
349
2374
(3020682) Albumin/Creatinine [Ratio] in Urine
220
3978
0.49
21.49
3.5
3.8
mg/mmol
5.3
10.9
2.53
134
2480
(3012516) Albumin [Mass/volume] in Urine
201
3728
0.48
21.10
2.7
3.1
mg/l
33.6
199.7
3.16
124
2343
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
26
30
8.77
20.68
1.2
1.2
%
—
71.6
—
0
5
(3018010) Neutrophils/100 leukocytes in Blood
355
5471
0.57
20.12
5.1
5.3
%
60.2
59.3
0.68
311
5009
(3009508) Creatinine [Moles/volume] in Urine
209
3758
0.50
19.80
2.6
3.0
mmol/l
7.3
6.8
1.05
152
3013
(3044889) 12 lead EKG panel
625
8344
0.62
19.73
3.8
4.3
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
393
5853
0.58
19.39
5.2
5.2
e9/l
1.7
1.9
1.22
319
5003
(3021589) Normoblasts [#/volume] in Blood
317
4993
0.56
19.25
8.1
10.1
e9/l
0.0
0.0
0.06
240
4031
(3001604) Monocytes [#/volume] in Blood
382
5697
0.59
18.79
5.3
5.1
e9/l
0.6
0.6
1.58
310
4776
(3002030) Lymphocytes/100 leukocytes in Blood
372
5584
0.58
18.75
5.0
5.6
%
25.2
25.4
0.06
321
5075
(3013115) Eosinophils [#/volume] in Blood
403
5925
0.59
18.72
5.2
5.3
e9/l
0.2
0.2
0.71
323
5065
(3006504) Eosinophils/100 leukocytes in Blood
363
5458
0.58
18.31
4.9
5.3
%
2.8
2.8
0.03
316
4984
(3006315) Basophils [#/volume] in Blood
388
5734
0.59
18.28
5.2
5.1
e9/l
0.0
0.0
1.42
312
4820
(3019069) Monocytes/100 leukocytes in Blood
365
5478
0.59
18.27
5.4
5.6
%
8.6
8.9
0.87
320
5017
(3022096) Basophils/100 leukocytes in Blood
351
5305
0.58
17.98
4.5
5.3
%
0.6
0.6
0.15
304
4847
(3013650) Neutrophils [#/volume] in Blood by Automated count
481
6712
0.62
17.71
7.1
7.9
e9/l
4.6
4.4
1.11
395
5759
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1001
11919
0.66
17.30
7.6
10.6
u/l
23.1
23.8
0.39
902
11334
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
138
2709
0.47
16.53
1.5
1.6
mmol/l
1.3
1.3
0.02
115
2224
(1761868) Lipid panel - Serum or Plasma
170
3053
0.51
15.51
3.1
3.3
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
686
8701
0.67
15.30
3.2
4.1
mm/h
14.1
16.1
2.49
592
7866
(3026493) Urate [Moles/volume] in Serum or Plasma
196
3312
0.54
14.52
2.2
2.7
umol/l
3422.6
8781.8
1.55
157
2740
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
57
1523
0.35
14.36
1.2
1.2
u/ml
7.1
13.8
0.78
19
516
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
348
5040
0.62
14.17
3.0
3.3
ng/l
2390.9
2377.3
0.01
272
4354
(3044640) Blood type and Crossmatch panel - Blood
263
4077
0.59
14.16
2.1
2.5
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
259
4017
0.59
13.93
3.8
5.2
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
725
8970
0.69
13.39
19.8
21.9
%
13.9
14.1
2.31
680
8689
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
185
3062
0.56
12.52
2.1
2.4
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
353
4971
0.64
12.29
2.4
2.8
ug/l
136.6
142.0
0.19
293
4418
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
70
1596
0.42
12.21
1.2
1.2
iu/ml
22.2
35.9
1.04
21
503
(3030467) Casts [#/volume] in Urine by Automated count
255
3850
0.61
12.02
3.3
3.4
e6/l
0.6
0.6
0.05
204
2984
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
793
9511
0.71
11.39
4.7
7.0
u/l
81.2
83.1
0.42
693
8782
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
518
6657
0.69
10.98
3.8
5.5
umol/l
12.7
12.6
0.02
455
6254
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
108
2003
0.51
10.58
2.2
2.4
%
20.7
20.4
0.06
75
1685
(3032080) INR in Blood by Coagulation assay
455
5950
0.69
10.49
10.0
11.6
inr
1.3
1.4
0.52
115
1574
(4035726)
38
1053
0.35
10.29
1.2
1.4
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
49
1206
0.39
10.22
1.2
1.3
titre
388.6
525.4
—
7
267
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
82
1642
0.48
10.08
2.1
3.5
u/l
250.8
251.4
0.01
65
1519
(3003694) ABO and Rh group [Type] in Blood
160
2606
0.58
9.99
1.2
1.3
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
139
2335
0.56
9.71
2.7
2.9
e6/l
1.8
1.5
0.31
80
1361
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
887
10317
0.73
9.71
4.2
4.7
mu/l
1.9
2.2
0.82
747
9089
(3004789) Transferrin [Mass/volume] in Serum or Plasma
122
2125
0.54
9.69
1.9
2.3
g/l
2.2
2.3
1.01
98
1937
(3013512) EKG study
287
4042
0.66
9.54
3.9
4.5
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
131
2216
0.56
9.37
3.1
3.1
e6/l
4.0
2.5
0.70
73
1258
(3022948) Iron [Moles/volume] in Serum or Plasma
139
2303
0.57
9.21
1.9
2.3
umol/l
11.5
11.5
0.02
109
2097
(36304419) Bacteria [Presence] in Urine
257
3679
0.65
9.20
3.2
3.4
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
102
1845
0.53
9.17
4.2
4.5
mmol/l
1.0
1.0
0.19
87
1667
(3002256) Pathology report gross observation
76
1500
0.49
8.94
1.4
1.4
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
78
1517
0.49
8.78
2.1
3.5
ug/l
7.5
21.0
1.17
62
1271
(3012095) Magnesium [Moles/volume] in Serum or Plasma
126
2104
0.57
8.56
2.2
2.8
mmol/l
0.8
0.8
1.30
112
1901
(3000492) Spirometry study
31
857
0.35
8.37
1.3
1.5
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
166
2563
0.61
8.26
1.5
1.6
mg/l
2.0
1.4
0.40
111
1990
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
542
6649
0.74
7.80
2.9
3.0
u/l
44.6
56.2
3.26
468
5996
(3033658) Prothrombin time (PT) actual/Normal
219
3132
0.66
7.64
3.2
3.8
%
84.3
83.0
0.29
208
3030
(40761511) CBC panel - Blood by Automated count
1037
11613
0.76
7.64
16.6
17.5
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
64
1267
0.49
7.59
4.5
5.6
mmol/l
13.3
12.2
0.37
55
1171
(3020630) Protein [Mass/volume] in Serum or Plasma
65
1280
0.49
7.59
1.3
2.4
g/l
65.5
65.6
0.04
54
1123
(3007164) IgA [Mass/volume] in Serum or Plasma
105
1762
0.57
7.23
1.3
1.4
g/l
2.6
2.6
0.10
53
989
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
235
1646
1.49
7.03
9.0
9.0
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
159
2370
0.64
6.70
2.7
3.3
ug/l
1.0
0.9
0.39
109
1659
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
199
2824
0.67
6.60
3.4
4.5
ng/l
326.0
298.3
0.07
158
2482
(3002582) Erythrocytes [#/volume] in Urine
327
4241
0.72
6.51
3.3
3.5
e6/l
88.0
85.1
0.03
257
3317
(40760892) CBC W Ordered Manual Differential panel - Blood
148
2221
0.64
6.42
4.2
4.2
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
733
8470
0.78
6.29
3.4
3.9
pmol/l
15.1
15.2
0.13
616
7436
(3004588) Protein electrophoresis panel - Serum or Plasma
55
1070
0.50
6.22
1.4
2.1
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
1128
12343
0.78
5.99
22.9
26.3
e9/l
242.3
240.7
0.34
1030
11887
(3022145) Colonoscopy Study observation
62
1145
0.53
5.96
1.2
1.3
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
1129
12346
0.79
5.92
22.9
26.5
g/l
129.3
130.0
0.73
1044
12031
(3026361) Erythrocytes [#/volume] in Blood
1129
12344
0.79
5.90
22.8
26.3
e12/l
4.3
4.3
0.91
1021
11827
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
26
90
2.92
5.89
1.0
1.5
—
—
—
0
0
(3024731) MCV [Entitic volume]
1129
12343
0.79
5.89
22.7
26.2
fl
91.5
91.8
1.51
1048
12013
(3035941) MCH [Entitic mass]
1129
12342
0.79
5.88
22.7
26.2
pg
30.3
30.4
0.80
1047
12012
(3010813) Leukocytes [#/volume] in Blood
1130
12348
0.79
5.84
22.8
26.3
e9/l
7.1
7.0
1.08
1022
11829
(4027681)
15
36
4.19
5.82
1.2
1.1
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
52
1003
0.50
5.74
2.8
3.8
%
2.4
0.9
0.40
15
321
(3023520) Reticulocytes [#/volume] in Blood
82
1376
0.58
5.65
1.8
2.3
e9/l
62.8
68.5
0.89
65
1069
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
25
87
2.90
5.62
1.3
1.3
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
54
1021
0.51
5.61
1.2
1.3
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
875
9825
0.80
5.61
17.7
19.8
%
36.6
37.3
0.68
447
5985
(3009445) Proteinase 3 Ab [Units/volume] in Serum
15
484
0.30
5.60
1.1
1.4
—
8.7
—
0
6
(3013826) Glucose [Moles/volume] in Serum or Plasma
653
7579
0.79
5.56
4.5
4.5
mmol/l
7.3
6.9
2.31
585
7121
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
262
3443
0.72
5.56
2.5
3.0
u/l
37.4
34.2
0.44
238
3248
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
64
1145
0.54
5.55
1.8
1.9
g/l
0.2
0.2
0.51
54
1054
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
16
42
3.83
5.54
1.0
1.0
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
17
47
3.64
5.48
1.1
1.0
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
45
894
0.49
5.44
2.4
3.7
%
1.0
0.6
—
9
224
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
24
606
0.39
5.40
1.0
2.0
g/l
4.2
3.7
1.04
18
416
(3026782) Osmolality of Urine
220
2948
0.71
5.24
3.0
3.0
mosm/kgh2o
583.1
541.2
2.28
178
2484
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
25
609
0.40
5.19
1.0
2.0
g/l
7.7
7.6
0.10
19
432
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
25
608
0.40
5.17
1.0
2.0
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
389
4780
0.77
5.15
3.9
4.0
e6/l
339.7
129.7
0.70
275
3547
(3021440) Promyelocytes/100 leukocytes in Blood
50
942
0.52
5.15
2.8
3.8
%
0.1
0.1
0.03
15
295
(3025159) Blasts/100 leukocytes in Blood
44
864
0.50
5.15
2.8
3.9
%
0.1
0.5
0.56
12
238
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
428
5188
0.77
5.09
2.5
2.3
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
329
4125
0.75
5.04
3.9
5.4
ug/l
3.9
5.2
0.54
276
3602
(40758558) Short blood count panel - Blood
223
2963
0.72
5.03
5.2
6.1
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
37
764
0.47
5.02
1.3
1.6
g/l
1.7
1.5
0.21
22
639
(3027945) Reticulocytes/100 erythrocytes in Blood
128
1878
0.66
4.97
1.9
2.2
%
1.7
1.8
0.47
97
1624
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
65
1111
0.57
4.82
3.1
3.3
ng/l
86.3
95.0
0.26
47
915
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
59
1032
0.56
4.76
1.4
1.3
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
339
2697
1.31
4.71
5.4
4.7
kg/l
1.0
1.0
0.42
49
450
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
11
380
0.29
4.71
1.4
1.6
—
160.0
—
0
22
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
309
3868
0.76
4.64
2.1
2.3
mg/l
3.3
3.3
0.03
234
3219
(40761535) Cells panel - Urine sediment
162
1147
1.45
4.61
3.7
3.6
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
1121
12128
0.81
4.55
19.2
21.9
mmol/l
4.0
4.0
0.48
1027
11694
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
409
4924
0.78
4.51
3.2
3.5
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
27
599
0.44
4.48
2.0
1.6
g/l
2.1
1.5
0.39
21
531
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
88
1366
0.63
4.45
2.1
2.5
umol/l
11.7
10.5
0.15
67
1175
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
102
1532
0.65
4.44
3.9
4.6
%
33.8
33.7
0.05
62
961
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
54
946
0.56
4.40
3.2
3.0
ml/min/173m2
64.4
58.0
0.70
22
425
(3019550) Sodium [Moles/volume] in Serum or Plasma
1121
12105
0.82
4.34
19.3
21.8
mmol/l
140.1
139.4
9.53
1032
11689
(3016502) Oxygen saturation in Arterial blood
97
1465
0.64
4.34
6.5
6.2
%
94.5
94.9
0.21
91
1397
(3006653) Thiamine [Moles/volume] in Blood
16
50
3.22
4.34
1.1
1.1
nmol/l
125.3
135.3
0.56
16
50
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
36
710
0.50
4.31
9.3
8.2
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
11
360
0.30
4.29
1.3
1.4
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
50
888
0.55
4.28
1.3
1.5
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
104
1536
0.66
4.18
1.3
1.2
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
48
854
0.55
4.14
3.6
4.2
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
134
1880
0.69
4.13
1.9
1.9
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
40
750
0.52
4.11
3.4
6.2
mmol/l
24.6
25.0
0.24
40
742
(3013139) Helicobacter pylori Ag [Presence] in Stool
33
656
0.49
4.07
1.3
1.2
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
7
248
0.28
4.00
1.7
1.4
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
116
1655
0.68
3.92
6.0
5.9
kpa
11.8
11.6
0.14
103
1551
(3003396) Base excess in Arterial blood by calculation
116
1655
0.68
3.92
6.1
6.0
mmol/l
1.1
1.3
0.29
86
1257
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
116
1654
0.68
3.91
6.0
5.9
kpa
4.9
5.1
0.70
103
1548
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
375
3101
1.26
3.81
1.7
1.7
pmol/l
456.9
10949923.3
1.57
305
2475
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
48
826
0.57
3.70
2.1
2.6
—
—
—
0
0
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
10
25
4.02
3.70
1.5
1.2
%
—
17.0
—
0
5
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
105
1507
0.68
3.67
2.6
3.2
ng/l
250.0
320.0
0.94
87
1362
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
23
494
0.46
3.57
4.3
2.6
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
14
46
3.06
3.53
1.2
1.2
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
10
26
3.86
3.52
1.1
1.1
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
10
306
0.32
3.49
1.2
1.3
—
8.2
—
0
5
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
0
91
0.00
3.48
0.0
1.7
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
128
1755
0.71
3.48
5.4
5.7
mmol/l
105.1
104.0
1.25
118
1704
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
15
52
2.90
3.46
1.1
1.1
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
76
1149
0.65
3.45
2.4
3.6
mmol/l
1.2
1.2
0.34
61
985
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
43
745
0.57
3.42
5.8
7.5
mmol/l
24.4
24.7
0.24
34
673
(3041096) Erythrocytes [Presence] in Urine by Automated
257
3173
0.78
3.39
3.9
4.1
—
—
—
0
0
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
13
42
3.11
3.37
3.1
3.1
umol/l
28.0
30.3
—
6
31
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
10
27
3.72
3.35
1.1
1.1
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
0
86
0.00
3.31
0.0
1.4
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
0
86
0.00
3.31
0.0
1.4
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
8
239
0.33
3.31
1.4
2.1
%
183.6
201.7
—
8
225
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
30
572
0.52
3.31
2.6
2.3
u/ml
0.4
0.4
0.13
17
331
(3012544) pH of Venous blood
110
1532
0.70
3.28
2.4
3.2
—
7.4
—
0
8
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
10
28
3.58
3.19
1.1
1.1
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
10
28
3.58
3.19
1.1
1.0
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
273
3317
0.79
3.14
3.9
4.7
%
20.3
22.1
1.30
131
1731
(21494755) Public health laboratory ask at order entry panel
16
371
0.43
3.07
1.2
1.4
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
152
1984
0.75
3.04
1.2
1.2
u/ml
2.5
1.5
0.24
44
510
(3000991) Gas panel - Venous blood
82
1181
0.68
2.96
4.2
6.4
—
—
—
0
0
(40768441) Liver Pathology biopsy report
0
76
0.00
2.96
0.0
1.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
40
227
1.78
2.96
1.1
1.2
—
—
—
0
0
(4010399)
47
763
0.61
2.95
1.4
1.4
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
5
180
0.28
2.95
1.0
1.4
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
11
294
0.37
2.95
1.5
1.5
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
46
750
0.60
2.94
2.2
3.2
e9/l
5.0
4.2
0.63
29
504
(4094501)
9
240
0.37
2.93
1.2
1.1
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1080
11518
0.85
2.88
17.1
18.3
mg/l
32.5
27.7
2.82
848
9591
(3005719) IgG [Mass/volume] in Serum or Plasma
46
746
0.61
2.88
2.0
2.6
g/l
10.3
10.7
0.38
38
668
(36660697) Celiac disease serology panel - Serum
40
671
0.59
2.87
1.2
1.1
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
784
8570
0.85
2.87
4.8
4.9
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
17
371
0.45
2.81
2.1
3.0
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
30
540
0.55
2.79
2.3
2.1
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
41
239
1.73
2.79
1.8
2.5
umol/l
34.1
33.2
0.05
33
185
(3018418) pH of Serum or Plasma
341
3991
0.82
2.73
2.6
3.7
ph
7.4
7.4
1.53
50
756
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
20
405
0.49
2.70
1.8
1.5
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
104
756
1.40
2.67
1.5
1.7
%
1.6
1.6
0.02
87
619
(3021447) Carbon dioxide [Partial pressure] in Venous blood
111
1484
0.73
2.62
2.4
3.2
kpa
5.8
5.8
0.10
102
1427
(3004119) Hemoglobin [Mass/volume] in Venous blood
64
941
0.67
2.60
2.4
3.0
g/l
126.7
124.6
0.42
64
917
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
8
20
4.01
2.57
1.3
1.0
miu/ml
2065.1
1479.9
—
8
20
(3002032) Base excess in Venous blood by calculation
111
1477
0.74
2.55
2.4
3.2
mmol/l
1.7
2.1
0.60
83
1152
(3000494) Fungus identified in Specimen by Culture
95
1293
0.72
2.52
1.2
1.4
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
617
6818
0.86
2.49
4.9
6.1
mmol/l
1.2
1.2
3.35
496
5647
(3019060) Gas panel - Arterial blood
68
979
0.68
2.49
6.3
4.1
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
438
4970
0.85
2.46
1.9
2.2
nmol/l
79.3
79.4
0.02
344
4264
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
550
6127
0.86
2.46
4.6
5.5
mmol/l
1.2
1.2
1.50
461
5425
(40768443) Skin Pathology biopsy report
33
556
0.59
2.45
1.2
1.2
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
257
3059
0.81
2.43
2.8
2.7
e6/l
6.0
5.1
0.62
220
2683
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
8
206
0.39
2.42
1.3
1.7
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
28
491
0.56
2.41
1.1
1.1
iu/ml
57.9
132.6
1.21
14
170
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
19
375
0.50
2.41
1.1
1.0
—
0.9
—
0
5
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
18
361
0.49
2.40
1.4
1.4
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
18
359
0.50
2.36
1.6
1.6
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
73
1022
0.70
2.31
1.5
1.7
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
9
28
3.22
2.30
1.1
1.1
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
6
13
4.63
2.27
1.2
1.0
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
315
2701
1.20
2.24
2.6
3.0
mmol/l
2.4
2.5
4.70
242
2313
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
27
466
0.57
2.22
1.7
1.8
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
5
9
5.57
2.21
1.0
1.0
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
346
3964
0.84
2.16
2.2
2.4
u/l
59.1
57.6
0.14
306
3636
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
14
294
0.47
2.15
1.2
1.8
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
83
1118
0.73
2.10
1.9
2.3
u/l
26.6
34.6
2.32
67
939
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
47
697
0.67
2.05
2.5
3.0
mmol/l
24.0
24.2
0.20
38
626
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
0
58
0.00
2.03
0.0
1.2
—
6.2
—
0
45
(3045424) Erythrocytes [Presence] in Urine
7
176
0.40
2.03
1.6
1.5
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
16
313
0.51
2.02
1.6
1.5
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
7
179
0.39
2.02
1.1
1.2
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
122
1546
0.77
2.02
1.6
1.7
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
162
0.37
2.01
1.2
1.5
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
20
362
0.55
1.98
1.5
1.2
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
19
98
1.95
1.95
2.7
2.5
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
35
543
0.64
1.91
3.2
3.0
pmol/l
4.5
4.4
0.26
28
458
(3014051) Protein [Presence] in Urine by Test strip
17
319
0.53
1.90
2.9
2.4
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
9
34
2.65
1.86
1.0
1.3
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
52
740
0.69
1.86
1.7
1.4
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
78
1037
0.74
1.84
2.0
1.9
ug/g
107.1
158.8
1.17
54
803
(3049717) Cytology report of Urine Cyto stain
40
597
0.66
1.83
2.6
2.8
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
14
66
2.13
1.82
1.2
1.7
umol/l
19.2
32.9
—
5
7
(3029937) Albumin [Presence] in Urine by Test strip
367
3250
1.16
1.78
5.1
4.6
estimate
0.0
0.0
0.50
61
1040
(3045142) Bone marrow Pathology biopsy report
5
134
0.37
1.75
1.6
1.2
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
97
1238
0.77
1.73
2.4
2.7
kpa
4.3
4.4
0.22
87
1185
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
5
13
3.85
1.71
1.2
1.0
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
11
229
0.48
1.70
1.4
1.9
mg/l
3.9
2.9
—
6
181
(3015377) Calcium [Moles/volume] in Serum or Plasma
498
4522
1.14
1.69
2.1
3.2
mmol/l
2.3
2.3
0.27
399
3795
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
10
42
2.39
1.67
1.4
1.1
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
35
524
0.66
1.65
3.8
5.2
—
—
—
0
0
(40768793) Breast Pathology biopsy report
13
252
0.51
1.64
1.1
1.3
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
556
6047
0.89
1.64
4.8
4.4
estimate
0.0
0.0
0.50
68
1095
(3024980) IgG subclass 4 [Mass/volume] in Serum
5
131
0.38
1.62
1.2
1.5
g/l
0.4
0.9
—
5
99
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
10
211
0.47
1.62
1.1
1.2
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
9
187
0.48
1.62
2.0
1.4
—
—
—
0
0
(3008898) HLA-B27 [Presence]
9
187
0.48
1.62
1.0
1.1
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
26
412
0.63
1.60
2.6
3.5
mmol/l
9.1
7.9
0.71
26
406
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
15
274
0.54
1.58
1.5
1.6
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
35
518
0.67
1.57
3.2
3.1
nmol/l
0.8
0.9
0.37
22
400
(40761536) Microorganisms panel - Urine sediment
79
1021
0.76
1.57
4.4
4.6
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
16
286
0.56
1.57
1.4
1.6
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
12
234
0.51
1.56
1.1
1.1
—
86.9
—
0
16
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
7
156
0.45
1.55
1.7
1.5
ug/l
11.5
18.8
—
7
150
(3028707) Methadone [Presence] in Urine by Screen method
8
33
2.43
1.53
1.3
1.1
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
14
258
0.54
1.52
1.1
2.9
u/ml
19.1
1473.4
—
9
242
(3034770) Mitochondria Ab [Titer] in Serum
13
245
0.53
1.52
1.1
1.2
—
656.3
—
0
8
(3043410) Blood group antigens tested for on Red Blood Cells
0
45
0.00
1.49
0.0
1.4
—
—
—
0
0
(4281824)
5
127
0.39
1.49
2.0
1.1
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
552
5971
0.89
1.46
6.0
5.9
estimate
0.0
0.0
0.00
69
1102
(3001019) Free T4 and TSH panel - Serum or Plasma
11
215
0.51
1.45
1.0
1.6
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
12
59
2.04
1.43
1.2
1.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
10
200
0.50
1.42
1.6
1.4
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
101
1246
0.80
1.40
3.7
5.4
mmol/l
1.7
1.4
1.39
93
1173
(40768806) Pleura Pathology biopsy report
10
198
0.50
1.38
1.7
1.6
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
72
922
0.77
1.36
9.7
6.0
mmol/l
24.7
24.4
0.26
67
856
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
75
955
0.78
1.36
2.4
3.6
kpa
5.1
5.2
0.20
62
861
(40767503) Oxygen content in Capillary blood by calculation
18
298
0.60
1.36
2.3
2.6
%
16.0
15.4
—
7
159
(3042631) Mycobacterium sp identified in Specimen
10
196
0.51
1.35
1.8
2.8
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
0
37
0.00
1.34
0.0
1.8
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
0
37
0.00
1.34
0.0
1.8
—
—
—
0
0
(3048879) Bone marrow aspiration report
0
38
0.00
1.34
0.0
1.7
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
39
0.00
1.33
0.0
1.8
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
10
47
2.13
1.33
1.3
1.1
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
16
271
0.59
1.32
1.1
1.2
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
40
0.00
1.32
0.0
1.3
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
11
207
0.53
1.31
1.3
2.7
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
10
194
0.51
1.31
1.7
1.4
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
41
0.00
1.31
0.0
1.0
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
6
24
2.50
1.30
2.7
2.5
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
6
24
2.50
1.30
2.7
2.5
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
17
281
0.60
1.29
2.0
2.5
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
6
131
0.46
1.28
1.2
1.2
—
—
—
0
0
(1002224) Polysomnography panel
14
242
0.58
1.26
1.0
1.1
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
45
608
0.73
1.26
2.4
2.2
nmol/l
10.7
11.4
0.26
39
508
(3006270) Folate [Moles/volume] in Blood
25
162
1.55
1.26
1.1
1.3
nmol/l
346.0
327.2
0.16
20
127
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
67
522
1.29
1.22
1.2
1.2
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
10
189
0.53
1.22
1.1
1.3
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
7
141
0.49
1.20
1.3
1.6
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
10
188
0.53
1.20
1.2
1.1
—
43.4
—
0
16
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
72
905
0.79
1.20
2.4
3.5
mmol/l
1.1
2.1
1.70
54
666
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
7
145
0.48
1.20
1.3
1.2
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
18
287
0.62
1.19
1.4
2.2
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
313
3459
0.89
1.19
1.4
1.6
nmol/l
20.8
20.2
0.28
264
2883
(4034850)
26
381
0.68
1.17
6.0
13.1
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
111
924
1.21
1.16
1.6
1.5
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
34
0.00
1.16
0.0
1.0
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
59
755
0.77
1.15
1.7
1.4
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
17
271
0.62
1.14
1.2
1.6
—
—
—
0
0
(3009343) pH of Capillary blood
76
940
0.80
1.12
2.3
3.6
ph
7.4
7.4
—
6
113
(3004809) Band form neutrophils/100 leukocytes in Blood
15
245
0.61
1.11
2.5
3.4
%
0.9
1.5
—
10
180
(4024509)
7
138
0.51
1.09
1.7
1.7
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
13
74
1.76
1.06
1.0
1.2
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
19
290
0.65
1.06
1.2
1.4
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
13
217
0.60
1.06
1.5
1.6
iu/l
2.0
5.2
—
5
72
(3030905) Polymorphonuclear cells [#/volume] in Blood
13
217
0.60
1.06
3.7
2.9
e9/l
4.7
4.7
0.02
13
217
(3014271) Vancomycin [Susceptibility]
21
137
1.54
1.05
3.5
3.2
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
6
124
0.48
1.05
1.2
1.5
u/l
12.5
14.3
—
6
111
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
8
148
0.54
1.03
1.6
1.6
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
10
178
0.56
1.03
1.5
1.5
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
560
5960
0.91
1.03
4.6
4.3
estimate
0.0
0.0
0.00
74
1111
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
9
48
1.88
1.00
2.0
2.5
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
9
48
1.88
1.00
2.0
2.5
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
5
110
0.45
1.00
3.8
1.7
mu/l
314.8
290.6
—
5
102
(3018677) aPTT in Platelet poor plasma by Coagulation assay
188
2119
0.87
0.99
1.6
1.8
s
29.2
30.0
1.84
180
2042
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
9
158
0.57
0.98
1.3
1.5
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
7
135
0.52
0.98
1.0
1.2
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
0
29
0.00
0.97
0.0
1.1
—
0.7
—
0
15
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
0
29
0.00
0.97
0.0
1.0
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
81
976
0.82
0.96
1.7
1.9
nmol/l
420.2
388.0
0.64
62
860
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
0
31
0.00
0.96
0.0
1.3
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
0
32
0.00
0.95
0.0
2.8
—
55763.9
—
0
8
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
10
173
0.58
0.95
1.3
1.6
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
35
465
0.75
0.93
2.0
2.8
g/l
0.2
0.3
—
6
168
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
8
145
0.55
0.93
1.1
1.1
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
11
182
0.60
0.89
1.2
1.2
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
17
254
0.67
0.89
1.2
1.2
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
8
42
1.91
0.88
1.0
1.2
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
7
128
0.55
0.88
1.3
1.2
—
0.2
—
0
8
(3022313) Gas panel - Capillary blood
55
681
0.80
0.87
2.2
3.6
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
15
228
0.66
0.86
3.5
3.3
%
59.6
60.6
0.17
15
228
(3019225) pH of Specimen
122
1400
0.86
0.85
4.3
4.4
—
—
—
0
0
(3022621) pH of Urine by Test strip
80
950
0.84
0.84
4.3
3.6
—
—
—
0
0
(3035880) pH of Pleural fluid
6
111
0.54
0.83
1.0
1.4
—
—
—
0
0
(4146454)
8
141
0.57
0.82
3.1
2.6
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
6
32
1.88
0.81
1.5
1.4
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
15
225
0.66
0.81
1.7
2.0
mmol/l
2.1
1.7
0.52
15
218
(3023419) Bacteria identified in Sputum by Culture
11
176
0.62
0.80
1.6
2.3
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
129
1132
1.15
0.79
1.5
1.6
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
0
24
0.00
0.79
0.0
1.3
—
113.0
—
0
19
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
24
0.00
0.79
0.0
1.1
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
24
0.00
0.79
0.0
1.8
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
25
0.00
0.79
0.0
1.1
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
0
25
0.00
0.79
0.0
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
25
0.00
0.79
0.0
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
25
0.00
0.79
0.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
25
0.00
0.79
0.0
1.1
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
13
199
0.65
0.78
1.4
1.5
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
13
199
0.65
0.78
1.2
1.2
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
50
403
1.25
0.77
1.5
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
50
403
1.25
0.77
1.5
1.4
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
29
382
0.76
0.76
2.1
1.5
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
27
200
1.36
0.76
30.2
7.4
mmol/l
7.9
7.5
0.24
19
171
(3000285) Sodium [Moles/volume] in Blood
0
28
0.00
0.76
0.0
1.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
10
59
1.70
0.75
1.3
1.1
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
44
351
1.26
0.75
3.1
3.8
mg/l
38.2
30.8
0.43
34
249
(3024891) Influenza virus A+B Ag [Presence] in Specimen
42
334
1.26
0.73
1.2
1.2
—
—
—
0
0
(44806118)
8
133
0.60
0.73
1.6
1.5
—
—
—
0
0
(44790048)
8
133
0.60
0.73
1.6
1.5
—
—
—
0
0
(44790049)
8
133
0.60
0.73
1.6
1.5
—
—
—
0
0
(44790047)
8
133
0.60
0.73
1.6
1.5
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
307
2848
1.09
0.73
5.1
4.2
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
7
39
1.80
0.72
2.0
1.8
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
22
299
0.73
0.72
2.1
2.8
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
10
60
1.67
0.72
1.3
1.1
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
10
60
1.67
0.72
1.3
1.1
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
37
467
0.79
0.72
1.4
1.3
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
9
57
1.58
0.71
1.3
1.1
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
24
320
0.75
0.70
2.1
2.3
ug/min
16.9
82.1
—
10
188
(3021788) Differential panel - Synovial fluid
16
228
0.70
0.69
1.7
1.5
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
13
85
1.53
0.69
1.5
1.6
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
7
118
0.59
0.68
1.3
1.2
—
—
—
0
0
(3038026) Centromere Ab [Units/volume] in Serum
5
93
0.54
0.67
1.0
1.2
—
74.4
—
0
6
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
393
4168
0.93
0.66
2.5
2.1
u/l
263.6
207.9
0.78
356
3864
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
5
95
0.53
0.66
1.2
1.1
%
123.4
115.4
—
5
86
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
16
225
0.71
0.65
1.2
1.3
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
12
178
0.67
0.65
1.4
1.4
—
—
—
0
0
(3003338) MCHC [Mass/volume]
872
8999
0.94
0.64
20.8
24.0
g/l
330.3
330.1
0.24
814
8833
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
55
655
0.83
0.64
2.2
1.8
ug/l
1.3
2.5
0.63
41
543
(3005570) Glucose [Moles/volume] in Urine
21
155
1.36
0.63
2.1
2.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
14
200
0.70
0.63
1.1
1.2
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
6
102
0.59
0.62
1.5
1.9
—
1.1
—
0
7
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
21
0.00
0.60
0.0
1.9
—
—
—
0
0
(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid
0
21
0.00
0.60
0.0
1.3
—
26.3
—
0
13
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
21
0.00
0.60
0.0
1.2
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
11
163
0.67
0.60
1.9
1.3
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
0
22
0.00
0.59
0.0
1.2
—
0.3
—
0
15
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
31
388
0.80
0.59
1.1
1.0
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
0
23
0.00
0.58
0.0
1.0
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
7
115
0.61
0.57
1.3
1.1
nmol/l
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
52
614
0.84
0.57
1.2
1.3
—
—
—
0
0
(3024263) Appearance of Synovial fluid
5
87
0.57
0.56
1.6
1.5
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
5
88
0.57
0.56
1.0
1.1
—
72.4
—
0
5
(3047007) Chlamydophila sp Ab [Presence] in Serum
5
88
0.57
0.56
1.0
1.3
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
5
89
0.56
0.56
1.0
1.2
—
55.9
—
0
9
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
5
90
0.55
0.55
1.0
1.2
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
6
37
1.62
0.55
1.0
1.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
6
37
1.62
0.55
1.8
1.5
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
9
61
1.48
0.53
1.3
1.1
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
26
327
0.79
0.53
2.8
4.7
kpa
5.2
5.0
0.31
26
319
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
244
2607
0.93
0.52
1.8
1.9
—
—
—
0
0
(3012501) Base excess in Blood by calculation
26
326
0.79
0.52
2.8
4.7
mmol/l
2.9
2.9
0.01
20
219
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
6
99
0.60
0.52
1.0
1.1
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
7
110
0.63
0.48
1.1
1.7
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
7
48
1.46
0.46
1.7
3.5
%
13.0
13.3
—
7
48
(3002523) Influenza virus A Ag [Presence] in Specimen
5
85
0.59
0.45
1.0
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
5
85
0.59
0.45
1.0
1.1
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
12
164
0.73
0.45
1.8
1.7
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
9
128
0.70
0.43
1.1
1.1
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
5
31
1.61
0.43
1.4
1.4
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
20
250
0.80
0.41
1.3
1.5
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
5
33
1.52
0.41
1.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
5
33
1.52
0.41
1.0
1.0
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
1.3
—
156.0
—
0
7
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
1.7
—
118.9
—
0
16
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
16
0.00
0.41
0.0
1.1
—
1.9
—
0
16
(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
1.1
—
98.6
—
0
10
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
0
17
0.00
0.40
0.0
4.7
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
0
18
0.00
0.40
0.0
1.1
—
82.5
—
0
13
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
7
103
0.68
0.39
1.3
1.6
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
49
559
0.87
0.39
2.5
4.0
mmol/l
24.3
25.0
1.07
43
492
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
7
106
0.66
0.39
1.1
1.7
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
0
19
0.00
0.39
0.0
1.7
—
35.1
—
0
9
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
19
0.00
0.39
0.0
1.6
—
—
—
0
0
(3024932) HLA-DR beta [Type]
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
12
158
0.76
0.37
1.9
3.8
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
13
168
0.77
0.35
1.0
1.5
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
13
168
0.77
0.35
1.0
1.5
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
13
168
0.77
0.35
1.0
1.5
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
9
122
0.74
0.35
1.1
1.1
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
10
73
1.37
0.34
1.9
1.7
u/field
0.2
3.9
—
5
51
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
13
167
0.78
0.34
1.0
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
13
167
0.78
0.34
1.0
1.5
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
153
1436
1.07
0.33
2.6
2.5
ug/l
6.6
6.2
0.07
100
1169
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
172
1821
0.94
0.32
1.7
1.8
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
7
97
0.72
0.31
1.1
1.1
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
41
462
0.88
0.30
4.4
3.8
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
13
163
0.80
0.29
4.5
3.8
—
—
—
0
0
(1616796) Gas panel - Central venous blood
27
313
0.86
0.29
2.1
4.0
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
60
658
0.91
0.28
2.0
1.9
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
224
2339
0.95
0.27
22.9
30.4
inr
1.4
1.5
0.31
21
289
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
174
1828
0.95
0.27
1.6
1.8
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
32
363
0.88
0.26
1.2
1.5
ug/g
297.2
272.2
0.33
20
225
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
36
319
1.13
0.26
1.1
1.2
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
5
73
0.68
0.26
1.2
1.1
%
97.0
98.4
—
5
68
(3017569) Oxygen content in Arterial blood
5
74
0.67
0.26
1.4
1.7
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
20
169
1.19
0.26
1.4
1.4
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
36
321
1.12
0.24
1.1
1.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
39
433
0.90
0.24
1.2
1.3
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
14
169
0.83
0.24
1.0
1.5
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
36
323
1.12
0.22
1.1
1.2
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
7
93
0.75
0.22
1.0
1.5
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
2.5
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3016330) Potassium [Moles/time] in 24 hour Urine
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.2
—
95.6
—
0
11
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
0
10
0.00
0.21
0.0
11.8
—
6.4
—
0
10
(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay
0
10
0.00
0.21
0.0
1.2
—
5521.0
—
0
5
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
590
5789
1.03
0.21
2.0
2.1
pmol/l
95.3
92.1
0.78
276
2940
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3035611) Eosinophils/100 leukocytes in Synovial fluid
0
13
0.00
0.21
0.0
1.8
—
0.3
—
0
8
(3012494) Peanut IgE Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.0
—
0.6
—
0
5
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
0
14
0.00
0.20
0.0
2.0
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
6
48
1.25
0.20
3.3
6.7
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
472
4621
1.03
0.20
5.1
4.7
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
9
112
0.80
0.20
1.1
1.3
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
9
112
0.80
0.20
1.0
1.3
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
9
112
0.80
0.20
1.1
1.3
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
20
174
1.15
0.19
2.0
2.1
u/field
2.2
2.7
—
5
46
(3020891) Body temperature
53
571
0.93
0.19
6.0
4.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
56
601
0.93
0.18
1.9
1.8
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
5
70
0.71
0.16
1.4
2.1
ug/l
0.9
3.2
—
5
63
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
8
72
1.11
0.16
1.1
1.2
u/l
10.4
27.1
—
8
56
(46235355) HIV 1 and 2 tests - Meaningful Use set
90
858
1.05
0.15
1.5
1.4
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
6
76
0.79
0.15
3.0
3.7
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
10
83
1.21
0.15
4.6
3.9
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
16
181
0.88
0.14
1.4
1.2
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
9
106
0.85
0.13
5.9
17.5
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
9
108
0.83
0.13
1.1
1.1
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
55
523
1.05
0.11
2.0
2.2
ug/l
1591.3
448.5
1.04
47
488
(3026008) Bacteria identified in Urine by Culture
476
4818
0.98
0.10
3.7
3.8
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
579
5846
0.99
0.09
3.4
4.3
g/l
34.7
34.1
1.47
491
5313
(3014148) Varicella zoster virus Ab [Titer] in Serum
5
47
1.06
0.09
1.0
1.2
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
15
136
1.10
0.08
1.2
1.3
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
20
216
0.93
0.08
1.8
1.6
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
5
60
0.83
0.08
1.0
1.1
—
4.1
—
0
9
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
8
77
1.04
0.07
1.1
1.2
u/l
58.8
91.0
—
8
62
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
7
82
0.85
0.07
1.1
1.9
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
17
181
0.94
0.05
1.2
1.1
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
561
5583
1.01
0.04
4.1
4.5
ng/l
65.8
63.2
0.06
401
4352
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
143
1446
0.99
0.03
3.9
3.9
—
—
—
0
0
(3015736) pH of Urine
469
4675
1.00
0.02
4.5
4.0
—
5.8
—
0
5
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
10
94
1.06
0.01
1.1
1.1
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
16
154
1.04
0.00
4.6
2.6
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
42
419
1.00
0.00
6.4
3.7
mmol/l
4.1
3.9
0.36
32
383
(3023368) Bacteria identified in Blood by Culture
429
4293
1.00
0.00
3.9
4.2
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
861
8610
1.00
0.00
5.8
5.4
e6/l
2240.6
1857.5
0.10
36
159
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
22.7
—
0
7
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3036525) Urea [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
5.6
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
3.0
—
88.6
—
0
8
(3019174) dRVVT (LA screen)
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay
0
8
0.00
0.00
0.0
1.0
—
102.7
—
0
8
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
8
87
0.92
0.00
3.1
2.4
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
0
7
0.00
0.00
0.0
13.3
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(44806071)
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013762) Body weight Measured
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(40758358) Immune stain study
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
6
0.00
0.00
0.0
1.0
—
36.9
—
0
6
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid
0
5
0.00
0.00
0.0
11.8
—
333.0
—
0
5
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
0
5
0.00
0.00
0.0
1.8
—
2.3
—
0
5
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(4306422)
9
99
0.91
0.00
1.3
1.2
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
0
5
0.00
0.00
0.0
2.8
—
—
—
0
0
(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
6
0.00
0.00
0.0
1.0
—
8.6
—
0
6
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
5
54
0.93
0.00
2.2
2.8
—
—
—
0
0
(3013466) aPTT in Blood by Coagulation assay
0
6
0.00
0.00
0.0
1.0
—
33.5
—
0
6
(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
10.0
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
8
84
0.95
0.00
1.1
1.3
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
6
68
0.88
0.00
2.3
2.3
—
—
—
0
0
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
0
6
0.00
0.00
0.0
1.2
—
7.7
—
0
6
(3019768) Coxiella burnetii Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
6
0.00
0.00
0.0
1.0
—
22.0
—
0
6
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3025315) Body weight
0
6
0.00
0.00
0.0
3.7
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
8
84
0.95
0.00
1.1
1.3
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: AD_EO – Alzheimer’s disease (Early onset)
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).